NLRP3 and Alzheimer disease: Abnormal microglial activation simulated by Aβ is fundamental for activation of the NLRP3 inflammasome and subsequent proinflammatory cytokine IL-1β/IL-18 release in the brains of AD patients (Saresella et al., 2016).